Oncology How AI is advancing patient subgroup identification in oncol... With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.
R&D How AI simulation could help de-risk obesity and cardiometab... AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.
Digital Sponsored From Pilot to Practice: Insights into AI Adoption, Impact, a... Read Medidata’s 2nd annual survey, 'The State of AI in Clinical Trials. From Pilot to Practice: Insights into AI Adoption, Impact, and Expectations'.
Digital AI in clinical trials: Building better trials before they st... With AI, trial sponsors are now reducing risk, accelerating timelines, and driving innovation by modelling what is most likely to work in the future.
R&D Drug discovery has a human biology problem The current opportunity lies in optimising existing discovery methodologies by generating more predictive, reproducible human data.
Digital The future of feasibility: AI-driven site selection & protoc... AI can help sponsors identify higher-potential sites, improve enrolment predictability, and accelerate study startup timelines.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.